Oppenheimer Initiates Coverage On Pulse Biosciences with Outperform Rating, Announces Price Target of $22
Benzinga Newsdesk 1 year ago
NewsPrice TargetInitiationAnalyst Ratings
Oppenheimer analyst Suraj Kalia initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Outperform rating and announces Price Target of $22.
Oppenheimer analyst Suraj Kalia initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Outperform rating and announces Price Target of $22.